Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer
Status:
Terminated
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
This pilot phase II trial studies how well pioglitazone works in treating patients with stage
IA-IIIA non-small cell lung cancer. Pioglitazone hydrochloride may slow the growth of tumor
cells and may be an effective treatment for non-small cell lung cancer.